Mounjaro Tracker App
Track Your Mounjaro Protocol
Mounjaro (Tirzepatide) is a gip+glp-1 dual agonist, FDA approved, used in SURMOUNT-1 with 20.9% weight loss at 72 weeks. Shotlee is the free app to track your complete Mounjaro protocol — doses, side effects, weight, and labs.
25,000+
Active Users
4.8★
App Rating
Free
Always Free
What Is Mounjaro?
Mounjaro (Tirzepatide) is a gip+glp-1 dual agonist, FDA approved, used in SURMOUNT-1 with 20.9% weight loss at 72 weeks. Shotlee is the free app to track your complete Mounjaro protocol — doses, side effects, weight, and labs.
Shotlee tracks every aspect of your Mounjaro protocol: injection dates, doses, sites, side effects, weight changes, and lab results. Whether you are starting or optimizing, clean data makes better decisions.
What to Track in Shotlee
Build a complete Mounjaro protocol record from day one.
Dose Log
Record every injection date, dose amount, and administration route.
Weekly Weight
Track body weight consistently to see your response curve over time.
Side Effects
Log any side effects with severity ratings to share with your prescriber.
Lab Results
Save blood work and biomarkers from clinic visits in one place.
Measurements
Waist, hip, and other measurements reveal changes the scale may miss.
Notes & Mood
Daily notes on energy, appetite, sleep, and overall wellbeing.
How to Track Your Mounjaro Protocol
Set a baseline: log your starting weight, measurements, and any available labs before your first dose
Record every dose: date, amount, injection site, and any immediate reactions
Log weekly weight at the same time and conditions to track your trend
Note side effects with severity so your prescriber can adjust your protocol
Add lab results from each clinic visit to measure biomarker improvements over time
Mounjaro Key Facts
Status
FDA Approved
Approved 2022
Typical Dose
2.5-15 mg/week SC
2.5-15 mg/week SC
Protocol FAQs
Mounjaro (tirzepatide) activates both GIP and GLP-1 receptors, while Ozempic only activates GLP-1. This dual action leads to greater weight loss (up to 22% vs 15%) and better blood sugar control.
Yes! Shotlee supports tracking multiple medications simultaneously. Many users track Mounjaro alongside metformin, insulin, or other diabetes medications.
Open the Shotlee app, navigate to the dose logging screen, select Mounjaro as your medication, and enter the dose amount, injection site, and time. Shotlee stores all entries with timestamps and lets you view your complete dose history, adherence rate, and missed dose alerts. The app is free to download and use.
The most important side effects to track include gastrointestinal symptoms (nausea, vomiting, diarrhea, constipation), injection site reactions, appetite changes, energy levels, and any unusual symptoms. Log these daily in Shotlee so you can share accurate trend data with your healthcare provider at your next visit.
Most patients begin noticing appetite changes within the first one to two weeks. Measurable weight loss typically becomes apparent by weeks four to eight, depending on the dose titration schedule and individual metabolic response. Track your weekly weight in Shotlee to visualize your personal response curve over time.
References
- [1]Clinical TrialJastreboff AM, et al. "Tirzepatide Once Weekly for the Treatment of Obesity." N Engl J Med. 2022;387(4):327-340.
- [2]Clinical TrialFrías JP, et al. "Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes." N Engl J Med. 2021;385(6):503-515.
- [3]FDAFDA. "Mounjaro (tirzepatide) injection, for subcutaneous use. Prescribing Information." NDA 215866. 2022.
- [4]Clinical TrialRosenstock J, et al. "Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1)." Lancet. 2021;398(10295):143-155.
Track Your Mounjaro Protocol in Shotlee
Free dose logs, side effect tracking, weight trends, and lab results — all in one app.
🚀 Use Shotlee for Free